Table 3.
Participant (PI scenario) | Number of Stage 1–compliant hypotheses | Number of final hypotheses in reduced dynamic envelope |
---|---|---|
S1 (I) | 1106 | 549 |
S1 (No I) | 1571 | 535 |
S2 (I) | 1017 | 621 |
S2 (No I) | 1115 | 894 |
(I), scenario where plasma insulin (PI) assays are available in Stage 1 identification; (No I), scenario where PI assays are unavailable.